The Oncosearch | Oncotarget

Extracorporeal blood filtration leading to tumor growth arrest and reduced analgesic requirements in Stage IV poorly differentiated pancreatic adenocarcinoma: A case report Case Report

Susanna Ulahannan, Peyton Smith, Jennifer Rios, Lakhmir Chawla

Published Jul 18, 2025 · Vol. 16, No. 1 · pp. 582-586

Keywords: extracorporeal blood filtration, circulating tumor cells, metastatic pancreatic cancer, seraph 100, OncoBind

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib Research Paper

Jinah Kim, Liam Il-Young Chung, Horyun Choi, Yoonhee Choi, Maria Jose Aguilera Chuchuca, Youjin Oh, Young Kwang Chae

Published May 21, 2025 · Vol. 16, No. 1 · pp. 411-418

Keywords: amivantamab, monotherapy, rare EGFR mutation, NSCLC, leptomeningeal disease

Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies Research Paper

Nina Klimova, Sandra Close, David M. Kurtz, Richard D. Hockett, Laura Hyland

Published May 2, 2025 · Vol. 16, No. 1 · pp. 329-336

Keywords: MRD, ctDNA, PhasED-Seq, CLARITY, residual disease

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review

Whitney L. Hensing, Emily L. Podany, James J. Sears, Shaili Tapiavala, Andrew A. Davis

Published Jan 9, 2025 · Vol. 16, No. 1 · pp. 11-27

Keywords: breast cancer, HER2-low, genomics

Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer Editorial

S.H. Tolmeijer, E. Boerrigter, N.P. Van Erp, Niven Mehra

Published Jun 19, 2024 · Vol. 15, No. 1 · pp. 421-423

Keywords: ctDNA, prostate cancer, liquid biopsy, biomarker, androgen receptor pathway inhibitors

Correction: Analytical validation of NeXT Personal^®, an ultra-sensitive personalized circulating tumor DNA assay Correction

Josette Northcott, Gabor Bartha, Jason Harris, Conan Li, Fabio C.P. Navarro, Rachel Marty Pyke, Manqing Hong, Qi Zhang, Shuyuan Ma, Tina X. Chen, Janet Lai, Nitin Udar, Juan-Sebastian Saldivar, Erin Ayash, Joshua Anderson, Jiang Li, Tiange Cui, Tu Le, Ruthie Chow, Randy Jerel Velasco, Chris Mallo, Rose Santiago, Robert C. Bruce, Laurie J. Goodman, Yi Chen, Dan Norton, Richard O. Chen, John M. Lyle

Published Apr 23, 2024 · Vol. 15, No. 1 · pp. 407-407

Analytical validation of NeXT Personal^®, an ultra-sensitive personalized circulating tumor DNA assay Research Paper

Josette Northcott, Gabor Bartha, Jason Harris, Conan Li, Fabio C.P. Navarro, Rachel Marty Pyke, Manqing Hong, Qi Zhang, Shuyuan Ma, Tina X. Chen, Janet Lai, Nitin Udar, Juan-Sebastian Saldivar, Erin Ayash, Joshua Anderson, Jiang Li, Tiange Cui, Tu Le, Ruthie Chow, Randy Jerel Velasco, Chris Mallo, Rose Santiago, Robert C. Bruce, Laurie J. Goodman, Yi Chen, Dan Norton, Richard O. Chen, John M. Lyle

Published Feb 21, 2024 · Vol. 15, No. 1 · pp. 200-218

Keywords: circulating tumor DNA, whole genome sequencing, molecular residual disease, tumor-informed assay, analytical validation

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies Review

Meghali Goswami, Jeffrey Schlom, Renee N. Donahue

Published Aug 3, 2023 · Vol. 14, No. 1 · pp. 758-774

Keywords: HPV-associated malignancies, immunotherapy, circulating tumor DNA, circulating tumor cells, HPV-specific antibodies

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells Research Paper

Mikolaj Filon, Bing Yang, Tanaya A. Purohit, Jennifer Schehr, Anupama Singh, Marcelo Bigarella, Peter Lewis, John Denu, Joshua Lang, David F. Jarrard

Published Jul 11, 2023 · Vol. 14, No. 1 · pp. 738-746

Keywords: prostate cancer, circulating tumor cells, p300/CBP

Correction: Changes in the cellular immune system and circulating inflammatory markers of stroke patients Correction

Chao Jiang, Weixia Kong, Yuejuan Wang, Wendy Ziai, Qingwu Yang, Fangfang Zuo, Fangfang Li, Yali Wang, Hongwei Xu, Qian Li, Jie Yang, Hong Lu, Jiewen Zhang, Jian Wang

Published Apr 27, 2023

Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity Editorial

Zhaoshan Liu, Swati Choksi, Zheng-Gang Liu

Published Apr 4, 2023 · Vol. 14, No. 1 · pp. 295-296

Keywords: necroptosis, breast cancer, metastasis, E-cadherin, immunity

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Tomofumi Miura, Shuichi Mitsunaga, Juntaro Matsuzaki, Satoko Takizawa, Ken Kato, Atsushi Ochiai, Takahiro Ochiya

Published Nov 29, 2022 · Vol. 13, No. 1 · pp. 1341-1349

Keywords: microRNA, early palliative care, integration, cancer, referral

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Tomofumi Miura, Shuichi Mitsunaga, Juntaro Matsuzaki, Satoko Takizawa, Ken Kato, Atsushi Ochiai, Takahiro Ochiya

Published Nov 29, 2022

Keywords: microRNA, early palliative care, integration, cancer, referral

Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival Review

Mark B. Ulanja, Alastair E. Moody, Bryce D. Beutler, Daniel Antwi-Amoabeng, Ganiyu A. Rahman, Olatunji B. Alese

Published Jun 4, 2022 · Vol. 13, No. 1 · pp. 828-841

Keywords: pancreatic cancer, gastrointestinal malignancy, epidemiology, pancreatic adenocarcinoma

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Ami N. Shah, Ashwin Sunderraj, Brian Finkelman, Sharlene H. See, Andrew A. Davis, Lorenzo Gerratana, Firas Wehbe, Neelima Katam, Deva Mahalingam, William J. Gradishar, Amir Behdad, Luis Blanco, Massimo Cristofanilli

Published Jan 26, 2022 · Vol. 13, No. 1 · pp. 273-280

Keywords: ERBB2, HER2, next-generation sequencing, copy number gain, circulating tumor DNA

Early detection of treatment futility in patients with metastatic colorectal cancer Research Paper

Jodi I. Rattner, Karen A. Kopciuk, Hans J. Vogel, Patricia A. Tang, Jeremy D. Shapiro, Dongsheng Tu, Derek J. Jonker, Lillian L. Siu, Chris J. O’Callaghan, Oliver F. Bathe

Published Dec 21, 2021 · Vol. 13, No. 1 · pp. 61-72

Keywords: colorectal cancer, metabolomics, response biomarkers, radiographic imaging, chemotherapy

Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses Research Paper

Diana P. Saraiva, Bruna F. Correia, Rute Salvador, Nídia de Sousa, António Jacinto, Sofia Braga, M. Guadalupe Cabral

Published Nov 15, 2021 · Vol. 12, No. 24 · pp. 2388-2403

Keywords: breast cancer, chemotherapy response, tumor-associated neutrophils, low density neutrophils, biomarker

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Research Paper

Phyllis A. Gimotty, Jacob E. Till, Shirsa Udgata, Naomi Takenaka, Stephanie S. Yee, Michael J. LaRiviere, Mark H. O’Hara, Kim A. Reiss, Peter O'Dwyer, Bryson W. Katona, Daniel Herman, Erica L. Carpenter, Kenneth S. Zaret

Published Oct 15, 2021 · Vol. 12, No. 22 · pp. 2266-2272

Keywords: pancreatic cancer, metastasis, biomarkers, prognosis, THBS2

NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells Research Paper

Adam S. Kittai, Olga V. Danilova, Vi Lam, Tingting Liu, Nur Bruss, Scott Best, Guang Fan, Alexey V. Danilov

Published Aug 23, 2021 · Vol. 12, No. 20 · pp. 2068-2074

Keywords: pevonedistat, T-cell lymphoma, chromosomal instability, anaphase catastrophe

Normal tissue and tumor microenvironment adaptations to aerobic exercise enhance doxorubicin anti-tumor efficacy and ameliorate its cardiotoxicity in retired breeder mice Priority Research Paper

Zachary R. Wakefield, Mai Tanaka, Christine Pampo, Sharon Lepler, Lori Rice, Joy Guingab-Cagmat, Timothy J. Garrett, Dietmar W. Siemann

Published Aug 18, 2021 · Vol. 12, No. 18 · pp. 1737-1748

Keywords: aerobic exercise, breast cancer, hypoxia, doxorubicin, cardiotoxicity

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Extracorporeal blood filtration leading to tumor growth arrest and reduced analgesic requirements in Stage IV poorly differentiated pancreatic adenocarcinoma: A case report Case Report

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib Research Paper

Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies Research Paper

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review

Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer Editorial

Correction: Analytical validation of NeXT Personal^®, an ultra-sensitive personalized circulating tumor DNA assay Correction

Analytical validation of NeXT Personal^®, an ultra-sensitive personalized circulating tumor DNA assay Research Paper

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies Review

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells Research Paper

Correction: Changes in the cellular immune system and circulating inflammatory markers of stroke patients Correction

Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity Editorial

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival Review

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Early detection of treatment futility in patients with metastatic colorectal cancer Research Paper

Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses Research Paper

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Research Paper

NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells Research Paper

Normal tissue and tumor microenvironment adaptations to aerobic exercise enhance doxorubicin anti-tumor efficacy and ameliorate its cardiotoxicity in retired breeder mice Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Extracorporeal blood filtration leading to tumor growth arrest and reduced analgesic requirements in Stage IV poorly differentiated pancreatic adenocarcinoma: A case report Case Report

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib Research Paper

Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies Research Paper

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review

Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer Editorial

Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay Correction

Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay Research Paper

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies Review

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells Research Paper

Correction: Changes in the cellular immune system and circulating inflammatory markers of stroke patients Correction

Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity Editorial

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival Review

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Early detection of treatment futility in patients with metastatic colorectal cancer Research Paper

Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses Research Paper

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Research Paper

NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells Research Paper

Normal tissue and tumor microenvironment adaptations to aerobic exercise enhance doxorubicin anti-tumor efficacy and ameliorate its cardiotoxicity in retired breeder mice Priority Research Paper

Correction: Analytical validation of NeXT Personal^®, an ultra-sensitive personalized circulating tumor DNA assay Correction

Analytical validation of NeXT Personal^®, an ultra-sensitive personalized circulating tumor DNA assay Research Paper